Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary Origin
Status:
Terminated
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
Therasphere is a form of treatment that has been designed to selectively deliver radiation to
the cancer within the patient's liver. This form of treatment has been used in a number of
clinical trials and has been approved for use in the treatment of liver cancer.
The investigators want to test the safety of using Gemcitabine (a chemotherapy drug) with
TheraSphere (radioactive beads that are injected directly into the blood vessel supplying the
tumor in the liver) in patients with advanced pancreatobiliary tumors such as pancreatic
cancer or cholangiocarcinoma (bile duct tumors) involving the liver.